332 related articles for article (PubMed ID: 29992772)
21. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
22. Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting.
Wang M; Nilsson G; Carlberg M; Dricu A; Wejde J; Kreicbergs A; Larsson O
Virchows Arch; 1998 Feb; 432(2):131-4. PubMed ID: 9504857
[TBL] [Abstract][Full Text] [Related]
23. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
24. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.
Urano F; Umezawa A; Yabe H; Hong W; Yoshida K; Fujinaga K; Hata J
Jpn J Cancer Res; 1998 Jul; 89(7):703-11. PubMed ID: 9738976
[TBL] [Abstract][Full Text] [Related]
26. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Fuchs B; Inwards C; Scully SP; Janknecht R
Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the molecular pathogenesis of Ewing's sarcoma.
Toomey EC; Schiffman JD; Lessnick SL
Oncogene; 2010 Aug; 29(32):4504-16. PubMed ID: 20543858
[TBL] [Abstract][Full Text] [Related]
28. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
[TBL] [Abstract][Full Text] [Related]
29. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
30. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
[TBL] [Abstract][Full Text] [Related]
31. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
32. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.
Downing JR; Head DR; Parham DM; Douglass EC; Hulshof MG; Link MP; Motroni TA; Grier HE; Curcio-Brint AM; Shapiro DN
Am J Pathol; 1993 Nov; 143(5):1294-300. PubMed ID: 8238248
[TBL] [Abstract][Full Text] [Related]
33. An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
Kedage V; Selvaraj N; Nicholas TR; Budka JA; Plotnik JP; Jerde TJ; Hollenhorst PC
Cell Rep; 2016 Oct; 17(5):1289-1301. PubMed ID: 27783944
[TBL] [Abstract][Full Text] [Related]
34. Type 1 (11;22)(q24:q12) translocation is common in Ewing's sarcoma/peripheral neuroectodermal tumour in south Indian patients.
Parija T; Shirley S; Uma S; Rajalekshmy KR; Ayyappan S; Rajkumar T
J Biosci; 2005 Jun; 30(3):371-6. PubMed ID: 16052075
[TBL] [Abstract][Full Text] [Related]
35. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
36. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.
Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T
Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288
[TBL] [Abstract][Full Text] [Related]
37. Detection of early prognostic biomarkers for metastasis of Ewing's sarcoma in pediatric patients.
Ezzeldin S; Osama A; Anwar AM; Mahgoub S; Ahmed EA; Farid N; Zamzam M; El Ghoneimy A; Magdeldin S
Life Sci; 2023 Dec; 334():122237. PubMed ID: 37926299
[TBL] [Abstract][Full Text] [Related]
38. EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
[TBL] [Abstract][Full Text] [Related]
39. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
40. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]